Collaborative Group on Hormonal Factors in Breast Cancer (1996). «Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies». Lancet347 (9017): 1713-27. PMID8656904. doi:10.1016/S0140-6736(96)90806-5.
Chlebowski R, Hendrix S, Langer R, Stefanick M, Gass M, Lane D, Rodabough R, Gilligan M, Cyr M, Thomson C, Khandekar J, Petrovitch H, McTiernan A (2003). «Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.». JAMA289 (24): 3243-53. PMID12824205. doi:10.1001/jama.289.24.3243.
inchem.org
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1999). «Hormonal contraceptives, progestogens only». Hormonal contraception and post-menopausal hormonal therapy; IARC monographs on the evaluation of carcinogenic risks to humans, Volume 72. Lyon: IARC Press. pp. 339-397. ISBN92-832-1272-X.
Collaborative Group on Hormonal Factors in Breast Cancer (1996). «Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies». Lancet347 (9017): 1713-27. PMID8656904. doi:10.1016/S0140-6736(96)90806-5.
Collaborative Group on Hormonal Factors in Breast Cancer (1996). «Breast cancer and hormonal contraceptives: further results». Contraception54 (3 Suppl): 1S-106S. PMID8899264.
Chlebowski R, Hendrix S, Langer R, Stefanick M, Gass M, Lane D, Rodabough R, Gilligan M, Cyr M, Thomson C, Khandekar J, Petrovitch H, McTiernan A (2003). «Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.». JAMA289 (24): 3243-53. PMID12824205. doi:10.1001/jama.289.24.3243.